Condition
Angle-closure Glaucoma
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06492538RecruitingPrimary
Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study
NCT00762645Phase 4CompletedPrimary
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
NCT05163093UnknownPrimary
Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular
NCT05563623RecruitingPrimary
The Beijing Angle Closure Progression Study
Showing all 4 trials